Related Experiment Video
Updated: May 3, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Recurrent hypo-attenuated leaflet thickening after TAVR: Clinical implications
Andrew Takla1, Kirolus Sourial2, Gaurav Sharma2
1Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA.
Subclinical bioprosthetic valve thrombosis (BPVT) is common in asymptomatic patients but its clinical significance remains unclear. This report clarifies the clinical implications of BPVT, aiding management strategies.
Area of Science:
- Cardiology
- Medical Imaging
- Thrombosis Research
Background:
- Subclinical bioprosthetic valve thrombosis (BPVT) is frequently detected in asymptomatic patients via imaging.
- The clinical significance and management of subclinical BPVT are not well-defined.
- Existing data link BPVT to adverse outcomes like increased valve gradients and thromboembolism.
Observation:
- BPVT presents a diagnostic and therapeutic challenge due to its dynamic nature.
- The optimal duration for anticoagulation therapy in BPVT is unpredictable.
- The necessity for frequent monitoring of subclinical BPVT requires further investigation.
Findings:
- This report elucidates the clinical implications of subclinical BPVT.
- Understanding these implications is crucial for patient management.
- The study aims to provide clarity on the clinical relevance of BPVT.
Implications:
- Provides critical insights into the clinical significance of subclinical BPVT.
- Informs clinical decision-making regarding anticoagulation and monitoring strategies.
- Contributes to improved patient outcomes and management protocols for bioprosthetic heart valves.
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management

